First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

CRXT Price Targets Summary
Clarus Therapeutics Holdings Inc

There are no price targets for CRXT.
CRXT Lowest Forecast
Wall Street Target
Not Available
CRXT Average Forecast
Wall Street Target
Not Available
CRXT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Clarus Therapeutics Holdings Inc Competitors:
Price Targets
JUBLPHARMA
Jubilant Pharmova Ltd
15% Upside
LABP
Landos Biopharma Inc
42% Downside
C
CURA
Curaleaf Holdings Inc
29% Upside
N
603538
Ningbo Menovo Pharmaceutical Co Ltd
68% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
15% Upside
LABP
Landos Biopharma Inc
42% Downside
C
CURA
Curaleaf Holdings Inc
29% Upside
N
603538
Ningbo Menovo Pharmaceutical Co Ltd
68% Upside
ERIS
Eris Lifesciences Ltd
17% Upside
M
MANKIND
Mankind Pharma Ltd
10% Downside
GLAND
Gland Pharma Ltd
7% Upside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Clarus Therapeutics Holdings Inc

For the last 1 year the compound annual growth rate for Clarus Therapeutics Holdings Inc's revenue is 119%. The projected CAGR for the next 2 years is 53%.

119%
Past Growth
53%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Clarus Therapeutics Holdings Inc

Operating Income forecast
is not available for
Clarus Therapeutics Holdings Inc

Net Income
Forecast

Net Income Estimate
Clarus Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
CRXT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRXT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRXT stock valuation using valuation multiples.
Wall Street Estimates
CRXT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRXT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRXT's stock price target?
Not Available

CRXT doesn't have any price targets made by Wall Street professionals.

What is Clarus Therapeutics Holdings Inc's Revenue forecast?
Projected CAGR
53%

For the last 1 year the compound annual growth rate for Clarus Therapeutics Holdings Inc's revenue is 119%. The projected CAGR for the next 2 years is 53%.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.